Candriam SCA’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-16,000
| Closed | -$887K | – | 820 |
|
|
2019
Q2 | $887K | Sell |
16,000
-8,000
| -33% | -$444K | 0.01% | 669 |
|
|
2019
Q1 | $1.21M | Hold |
24,000
| – | – | 0.02% | 591 |
|
|
2018
Q4 | $967K | Hold |
24,000
| – | – | 0.01% | 589 |
|
|
2018
Q3 | $1.66M | Hold |
24,000
| – | – | 0.02% | 541 |
|
|
2018
Q2 | $1.82M | Hold |
24,000
| – | – | 0.03% | 509 |
|
|
2018
Q1 | $1.27M | Hold |
24,000
| – | – | 0.02% | 552 |
|
|
2017
Q4 | $1.28M | Sell |
24,000
-35,000
| -59% | -$1.87M | 0.02% | 535 |
|
|
2017
Q3 | $3.52M | Buy |
59,000
+11,000
| +23% | +$656K | 0.06% | 343 |
|
|
2017
Q2 | $3.79M | Hold |
48,000
| – | – | 0.07% | 328 |
|
|
2017
Q1 | $3.98M | Sell |
48,000
-14,000
| -23% | -$1.16M | 0.08% | 299 |
|
|
2016
Q4 | $4.92M | Sell |
62,000
-5,000
| -7% | -$397K | 0.11% | 215 |
|
|
2016
Q3 | $4.69M | Buy |
67,000
+12,000
| +22% | +$840K | 0.11% | 201 |
|
|
2016
Q2 | $2.13M | Sell |
55,000
-2,500
| -4% | -$97K | 0.06% | 299 |
|
|
2016
Q1 | $2.32M | Buy |
+57,500
| New | +$2.32M | 0.06% | 299 |
|